Document is current
Any future updates will be listed below
-
Authors
Bharat, Chrianna https://orcid.org/0000-0002-9778-0386
Hopkins, Ria E. https://orcid.org/0000-0001-9822-7083
Chambers, Mark https://orcid.org/0000-0001-9121-6111
Degenhardt, Louisa https://orcid.org/0000-0002-8513-2218
Peacock, Amy https://orcid.org/0000-0002-5705-2026
Farrell, Michael https://orcid.org/0000-0001-7008-8130
Yuen, Wing See https://orcid.org/0000-0002-2791-6858
Man, Nicola https://orcid.org/0000-0003-2224-9301
Gisev, Natasa https://orcid.org/0000-0003-0452-8470
-
Funding
Funding for this research was provided by:
NHMRC Investigator Grants (2016825, 1174630)
University of New South Wales
- License Information
-
More Information
Article History
Received: 5 February 2024
Accepted: 15 August 2024
First Online: 23 August 2024
Declaration
:
: LD has received untied educational funding from Reckitt Benckiser, Indivior, Mundipharma Pty Ltd, and Seqirus. AP has received untied educational grants from Seqirus and Mundipharma for study of opioid medications. These untied grants are all unrelated to the current study. All other authors declare no competing financial or non-financial interests.
